EconomyThe storm is (mostly) behind us, says HAMISH MCRAEApril 8, 2023186By Hamish Mcrae, Financial Mail On Sunday 21:52 08 Apr 2023, updated 21:52 08 Apr 2023 It is time for...
CurrenciesNext boss: downturn in UK economy won’t be long lastingMarch 29, 2023181Recent gauges of Britain's economy, such as consumer confidence data, have suggested it could sidestep a prolonged recession which had...
CurrenciesThe secret iPhone hack that helps you translate languages and convert currenciesMarch 24, 2023222A lesser-known iPhone tool – known as ‘Live Text’ - can translate foreign text in a matter of seconds IPhone users...
CurrenciesChina Jan-Feb fiscal revenue shrinks despite pick-up in economyMarch 17, 2023198Data this week showed the world's second-largest economy is gradually recovering since pandemic curbs were abruptly dropped in December, but...
Stock MarketInsurance software on the block as private equity looks to cash in – sourcesMarch 3, 2023192Montagu is exploring a sale of Open GI, which offers software for insurance brokers to run their operations, in a...
CurrenciesBrazil’s financial committee keeps countercyclical rate at 0%, scraps riskMarch 2, 2023192BRASILIA, March 2 (Reuters) - Brazil's banking system is prepared against risks and recording positive results in credit concessions despite...
CurrenciesRussia declares battlefield gains as NATO ramps up military equipment for UkraineFebruary 15, 2023190Bolstered by tens of thousands of reservists drafted in December, Russia has intensified attacks across southern and eastern Ukraine in...
BankingProparco and the European Union support Bank of Palestine in financing high impact SMEsFebruary 14, 202317814/02/2023 Proparco and the European Union support Bank of Palestine in financing high impact SMEs After an equity investment in...
Mortgages‘Zillennials’ who moved back to the ‘Hotel of Mom and Dad’February 11, 2023191Nearly half of 18-29-year-olds still live at home, according to the US census Flush with disposable income, many are now propping...
Stock MarketForxiga approved in EU for chronic heart failureFebruary 7, 2023240Forxiga (dapagliflozin) has been approved in the European Union for heart failure (HF) with reduced ejection fraction (HFrEF) across the...